Hierarchical role for transcription factors and 2007 chromatin structure in genome organization along adipogenesis. The FEBS, Mandrup, vol.284, pp.3230-3244, 2006. ,
Extensive chromatin remodelling and establishment of 2011 transcription factor 'hotspots' during early adipogenesis, The EMBO journal, vol.2012, pp.1459-1472, 2011. ,
Structure of the intact PPAR-gamma-RXR-alpha nuclear receptor complex 2015 on DNA, Nature, pp.350-356, 2008. ,
Retinoid X 2017 receptors in macrophage biology, Trends Endocrinol Metab, vol.24, pp.460-468, 2013. ,
, , 2019.
, , p.2020
Cross-talk between peroxisome 2021 proliferator-activated receptor (PPAR) alpha and liver X receptor (LXR) in 2022 nutritional regulation of fatty acid metabolism. II. LXRs suppress lipid 2023 degradation gene promoters through inhibition of PPAR signaling, Endocrinol, vol.17, pp.1255-1267, 2003. ,
, , p.2026
Cross-talk between 2028 peroxisome proliferator-activated receptor (PPAR) alpha and liver X receptor 2029 (LXR) in nutritional regulation of fatty acid metabolism. I. PPARs suppress 2030 sterol regulatory element binding protein-1c promoter through inhibition of 2031 LXR signaling, Mol Endocrinol, vol.17, pp.1240-1254, 2003. ,
Cross-talk between thyroid hormone receptor and liver X 2034 receptor regulatory pathways is revealed in a thyroid hormone resistance 2035 mouse model, J Biol Chem, vol.281, pp.295-302, 2006. ,
, Peroxisome Proliferator Activated Receptor-alpha Association With Silent 2038 Information Regulator 1 Suppresses Cardiac Fatty Acid Metabolism in the 2039 Failing Heart, Circulation Heart failure, vol.8, pp.1123-1132, 2015.
, , 2041.
PPARalpha-Sirt1 complex mediates cardiac hypertrophy and 2042 failure through suppression of the ERR transcriptional pathway, Cell 2043 metabolism, vol.14, pp.598-611, 2011. ,
Vanden Heuvel 2051 JP. The ribosomal protein rpL11 associates with and inhibits the 2052 transcriptional activity of peroxisome proliferator-activated receptor-alpha, Toxicological sciences : an official journal of the Society of Toxicology, vol.11, pp.535-546, 2006. ,
, , p.2500
, , p.2501
Journal of medicinal peroxisome-proliferator-activated receptors alpha and delta in fibrate and 2799 fatty-acid-mediated inductions of the gene encoding liver fatty-acid-binding 2800 protein in the liver and the small intestine, The Biochemical journal, vol.2801, pp.481-488, 2001. ,
Targeted disruption of the alpha 2804 isoform of the peroxisome proliferator-activated receptor gene in mice results 2805 in abolishment of the pleiotropic effects of peroxisome proliferators, Molecular and cellular biology, vol.15, pp.3012-3022, 1995. ,
, , p.2808
Fatty Acid-binding Proteins 1 and 2 2809 Differentially Modulate the Activation of Peroxisome Proliferator-activated 2810 Receptor alpha in a Ligand-selective Manner, J Biol Chem, vol.290, pp.13895-2811, 2015. ,
The gene encoding acyl-CoA-binding protein is subject to 2814 metabolic regulation by both sterol regulatory element-binding protein and 2815 peroxisome proliferator-activated receptor alpha in hepatocytes, J Biol Chem, vol.2816, pp.5258-5266, 2005. ,
, , p.2818
, , p.2819
The gene encoding the Acyl-CoA-binding protein is activated by 2820 peroxisome proliferator-activated receptor gamma through an intronic 2821 response element functionally conserved between humans and rodents, J Biol, vol.277, pp.26821-26830, 2002. ,
, , p.2824
Long-chain fatty acids regulate liver carnitine 2825 palmitoyltransferase I gene (L-CPT I) expression through a peroxisome-2826 proliferator-activated receptor alpha (PPARalpha)-independent pathway, The 2827 Biochemical journal, vol.354, pp.189-197, 2001. ,
Control of human carnitine 2829 palmitoyltransferase II gene transcription by peroxisome proliferator-activated 2830 receptor through a partially conserved peroxisome proliferator-responsive 2831 element, The Biochemical journal, vol.369, pp.721-729, 2003. ,
Peroxisome proliferator-2833 activated receptor alpha (PPARalpha) agonist treatment reverses PPARalpha 2834 dysfunction and abnormalities in hepatic lipid metabolism in ethanol-fed mice ,
, J Biol Chem, vol.278, pp.27997-28004, 2003.
The peroxisome 2837 proliferator-activated receptor regulates mitochondrial fatty acid oxidative 2838 enzyme gene expression, Proceedings of the National Academy of Sciences of 2839 the United States of America, vol.91, pp.11012-11016, 1994.,
DOI : 10.1073/pnas.91.23.11012
URL : http://www.pnas.org/content/91/23/11012.full.pdf
PPARalpha activation protects against 2841 cholestatic liver injury, Scientific reports, vol.7, p.9967, 2017.,
DOI : 10.1038/s41598-017-10524-6
URL : https://www.nature.com/articles/s41598-017-10524-6.pdf
, , p.2843
Peroxisomal and mitochondrial fatty acid 2844 beta-oxidation in mice nullizygous for both peroxisome proliferator-activated 2845 receptor alpha and peroxisomal fatty acyl-CoA oxidase. Genotype correlation 2846 with fatty liver phenotype, J Biol Chem, vol.274, pp.19228-19236, 1999. ,
, The Biochemical journal, vol.351, pp.747-753, 2000.
Peroxisome proliferator-activated receptor alpha 2949 (PPARalpha) and agonist inhibit cholesterol 7alpha-hydroxylase gene 2950 (CYP7A1) transcription, Journal of lipid research, vol.41, pp.514-520, 2000. ,
PPAR gamma 2 2952 regulates adipose expression of the phosphoenolpyruvate carboxykinase gene, Molecular and cellular biology, vol.15, pp.351-357, 1995. ,
Peroxisome-2955 proliferator-activated receptor-alpha (PPARalpha) deficiency leads to 2956 dysregulation of hepatic lipid and carbohydrate metabolism by fatty acids and 2957 insulin, The Biochemical journal, vol.364, pp.361-368, 2002. ,
Fibrates and statins rapidly and synergistically induce 2959 pyruvate dehydrogenase kinase 4 mRNA in the liver and muscles of mice ,
, Biological & pharmaceutical bulletin, vol.26, pp.954-958, 2003.
Characterization of the fasting-induced adipose 2963 factor FIAF, a novel peroxisome proliferator-activated receptor target gene, J 2964 Biol Chem, vol.275, pp.28488-28493, 2000. ,
, , 2966.
Opposite regulation of 2967 human versus mouse apolipoprotein A-I by fibrates in human apolipoprotein 2968 A-I transgenic mice, J Clin Invest, vol.97, pp.2408-2416, 1996. ,
Pharmacodynamic 2970 activity of lipoprotein lipase and hepatic lipase, and pharmacokinetic 2971 parameters measured in normolipidaemic subjects receiving ciprofibrate (100 2972 or 200 mg/day) or micronised fenofibrate (200 mg/day) therapy for 23 days, Atherosclerosis, vol.124, pp.65-73, 1996. ,
Auwerx 2975 J. Alterations in lipoprotein metabolism in peroxisome proliferator-activated 2976 receptor alpha-deficient mice, J Biol Chem, vol.272, pp.27307-27312, 1997. ,
Fibrates influence the expression of 2978 genes involved in lipoprotein metabolism in a tissue-selective manner in the 2979 rat, Arteriosclerosis and thrombosis : a journal of vascular biology, vol.2980, pp.286-294, 1992. ,
, , p.2982
, Hypolipidemic activity of select fibrates correlates to changes in hepatic 2984 apolipoprotein C-III expression: a potential physiologic basis for their mode of 2985 action, Journal of lipid research, vol.36, pp.2541-2551, 1995.
Fatty acids activate transcription of the 2987 muscle carnitine palmitoyltransferase I gene in cardiac myocytes via the 2988 peroxisome proliferator-activated receptor alpha, J Biol Chem, vol.2989, p.2991, 1998. ,
Uncoupling protein 3 transcription is regulated by 2992 peroxisome proliferator-activated receptor (alpha) in the adult rodent heart. 2993 FASEB journal : official publication of the Federation of American Societies 2994 for, Proceedings of the National Academy of Sciences of the United States of 3045 America, vol.15, pp.4653-4657, 1992. ,
Elevated lipoprotein lipase activity in 3047 skeletal muscle tissue during treatment of hypertriglyceridaemic patients with 3048 bezafibrate, Atherosclerosis, vol.44, pp.113-118, 1982. ,
Free fatty 3050 acid metabolism during fenofibrate treatment of the metabolic syndrome ,
, Clinical pharmacology and therapeutics, vol.74, pp.236-244, 2003.
, , p.3053
Increase in 3054 lipoprotein lipase during clofibrate treatment of hypertriglyceridemia in 3055 patients on hemodialysis, The New England journal of medicine, vol.3056, pp.1073-1076, 1979. ,
Increase of the 3058 lipoprotein-lipase activity in human skeletal muscle during clofibrate 3059 administration, European journal of clinical investigation, vol.8, pp.67-74, 1978. ,
Influence of PPAR-alpha agonist fenofibrate on insulin 3062 sensitivity and selected adipose tissue-derived hormones in obese women with 3063 type 2 diabetes, Physiological research, vol.56, pp.579-586, 2007. ,
Fenofibrate 3065 reduces serum retinol-binding protein-4 by suppressing its expression in 3066 adipose tissue, Am J Physiol Endocrinol Metab, vol.296, pp.628-634, 2009. ,
Effect of gemfibrozil on adipose tissue and 3068 muscle lipoprotein lipase, Metabolism: clinical and experimental, vol.3069, pp.1486-1491, 1993. ,
Clofibrate increases lipoprotein-lipase 3071 activity in adipose tissue of hypertriglyceridaemic patients, Lancet, p.3072 ,
, , vol.2, pp.1106-1107, 1977.
Effect of a 3074 six month gemfibrozil treatment and dietary recommendations on the 3075 metabolic risk profile of visceral obese men, Int J Obes Relat Metab Disord, vol.3076, pp.1136-1143, 2001. ,
A pilot trial of fenofibrate for the treatment of non-3079 alcoholic fatty liver disease. Digestive and liver disease : official journal of the 3080 Italian Society of Gastroenterology and the Italian Association for the Study of 3081 the, Liver, vol.40, pp.200-205, 2008. ,
3083 Effects of peroxisome proliferator-activated receptor (PPAR)-alpha and 3084 PPAR-gamma agonists on glucose and lipid metabolism in patients with type 3085 2 diabetes mellitus, Diabetologia, vol.50, pp.1723-1731, 2007. ,
, , p.3087
, , p.3088
Short-term intensive treatment for donors with hepatic 3089 steatosis in living-donor liver transplantation, Transplantation, vol.80, p.612, 2005. ,
Inhibition of 3092 inducible nitric oxide synthase by peroxisome proliferator-activated receptor ,
Peroxisome proliferator-activated receptors (PPARs) in 3437 skin health, repair and disease, Biochim Biophys Acta, vol.1771, pp.991-998, 2007. ,
, , p.3439
Impaired skin wound healing in peroxisome proliferator-3441 activated receptor (PPAR)alpha and PPARbeta mutant mice, The Journal of 3442 cell biology, vol.154, pp.799-814, 2001. ,